Construction Spending in

Oregon

Oregon's biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.

Construction Employment

Union Labor & Earnings, 2012–17

Pharmaceutical & Biotech

420,562

Labor Hours Demanded

(14 trades, installation, and maintenance)

97,382

Union Labor Hours (est)

(State union% in non-residential = 23.2%)

$30.06

Average Union Wage

(Union construction workers, 2017 dollars)

$2.9

million

Total Union Earnings (est.)

(Union hours times average wage)

Industry Analysis: Oregon

Pharmaceutical Manufacturing (2017)

Firms

51

Firms

Employees

929

Employees

Annual Wages

$54

million

Annual Wages

Oregon Construction Labor Hours by Trade

Pharmaceutical & Biotech, 2012–17

4,307

Installation

890

Maintenance

5,197

Total hours

Largest Construction Projects

Pharmaceutical & Biotech Manufacturing, 2012–17

Genentech (Roche USA) Incorporated

Hillsboro Biotherapeutic Fill/Finish Plant Life Bldg 2 Production Suite Addition

Hillsboro, OR

125,000,000

2016-2017

Bend Research Incorporated

Bend Solid Oral Dose and HPAPI Development Plant Addition

Bend, OR

35,000,000

2017-2019

Bend Research Incorporated

Bend Pilot-Scale Solid Oral Dose CMO Plant Expansion

Bend, OR

25,000,000

2014-2015

Patheon, part of Thermo Fisher Scientific

Bend Pre-Clinical Oral, Solids, Capsules, Liquid CDMO Spray Drying Line Add+Reno

Bend, OR

5,700,000

2016-2018

Genentech (Roche USA) Incorporated

Hillsboro Biotherapeutic Fill/Finish Plant Life Bldg 2 Production Suite Addition

Hillsboro, OR

Location

125,000,000

Project Value

2016-2017

Years

Take Action

Share the study results and spread the word about the connection between the biopharmaceutical industry and union construction workers in Oregon!

You may be surprised by the connection between Oregon's biopharmaceutical industry and union labor. A new study finds that from 2012-2017 America’s biopharmaceutical companies invested $209 million in infrastructure in the state, supporting more than 97,000 union labor hours. View Oregon's labor-industry profile here: https://bit.ly/2L5caVw

Oregon's pharmaceutical companies and the building trades unions have a surprising relationship - a new study finds that from 2012- 2017 biopharmaceutical companies invested $209 million in infrastructure in the state, supporting more than 97,000 union labor hours. View Oregon's labor-industry profile here: https://bit.ly/2L5caVw

A new study finds that from 2012-2017 Oregon's biopharmaceutical companies invested $209 million in infrastructure in the state, supporting more than 97,000 union labor hours. Learn more: https://bit.ly/2L5caVw